Families facing rare muscle disease are pushing for an experimental gene therapy, but the FDA is skeptical
SRP-9001, an experimental gene therapy that aims to slow or stop the progression of Duchenne muscular dystrophy, is being considered for accelerated approval by the FDA.
2023-05-12 22:27
U.S. FDA advisers back Perrigo birth control pill for over-the-counter use
By Sriparna Roy and Nandhini Srinivasan (Reuters) -A U.S. Food and Drug Administration advisory panel on Wednesday voted in favor
2023-05-11 12:50
FDA advisers vote unanimously in support of over-the-counter birth-control pill
Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making a birth control pill named Opill available over-the-counter, saying the benefits outweigh the risks.
2023-05-11 01:47
As FDA advisers consider OTC birth-control pill, agency scientists worry it won't work due to women's weight and likelihood of following label
On Tuesday and Wednesday, a group of external advisers to the US Food and Drug Administration will discuss an application from a pharmaceutical company to put their prescription birth control pill over-the-counter.
2023-05-09 19:54